NovoCure

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.

About NVCR

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.

CEO

Ashley Cordova

CEOAshley Cordova

Employees

1,488

Employees1,488

Headquarters

St. Helier, Jersey

HeadquartersSt. Helier, Jersey

Founded

2000

Founded2000

Employees

1,488

Employees1,488

NVCR Key Statistics

Market cap

1.31B

Market cap1.31B

Price-Earnings ratio

-7.96

Price-Earnings ratio-7.96

Dividend yield

—

Dividend yield—

Average volume

1.39M

Average volume1.39M

High today

$12.50

High today$12.50

Low today

$11.65

Low today$11.65

Open price

$12.41

Open price$12.41

Volume

1.30M

Volume1.30M

52 Week high

$34.13

52 Week high$34.13

52 Week low

$10.87

52 Week low$10.87

NVCR News

Simply Wall St 8h

NovoCure: How FDA Filing for TTFields in Pancreatic Cancer Shapes the Stock’s Valuation Outlook

If you have been keeping tabs on NovoCure (NVCR), you probably noticed the latest surge in conversation: the company has just filed a premarket approval applica...

TipRanks 9h

Novocure announces coverage for Tumor Treating Fields therapy in Spain

Novocure (NVCR) announced that Spain’s Ministry of Health has made Tumor Treating Fields therapy available through the Spanish National Health System for the tr...

Simply Wall St 2d

NovoCure Is Up 6.0% After FDA Submission for TTFields in Pancreatic Cancer

Earlier this week, NovoCure announced it had submitted a premarket approval application to the FDA for TTFields therapy in locally advanced pancreatic cancer, s...

Analyst ratings

63%

of 8 ratings

Buy

62.5%

Hold

37.5%

Sell

More NVCR News

Simply Wall St 4d

Investors Give NovoCure Limited Shares A 27% Hiding

Unfortunately for some shareholders, the NovoCure Limited ( ) share price has dived 27% in the last thirty days, prolonging recent pain. Instead of being reward...

People also own

Based on the portfolios of people who own NVCR. This list is generated using Robinhood data, and it’s not a recommendation.